TrialAntimicrobial agents and chemotherapy2013

Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.

Jean-Jacques Parienti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.